Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 116 record(s)

Req # A-2022-000282

Adverse Drug Reactions (ADRs). Report numbers: 000977325, E2B_04921399, 000978467, E2B_04875737, 000977213, E2B_04402148, E2B_04845335, 000978206, E2B_04920318, E2B_04580127.

Organization: Health Canada

218 page(s)
August 2022

Req # A-2022-000292

Adverse Drug Reactions (ADRs). Report numbers: E2B_03821961, E2B_04486099, E2B_04712176, E2B_04942699, E2B_04856187, E2B_04938771, E2B_04938745, E2B_04797467, E2B_04867666, 000975762.

Organization: Health Canada

119 page(s)
August 2022

Req # A-2022-000294

Adverse Drug Reactions (ADRs) for Intron A. Report numbers: E2B_03022099, E2B_03022079, E2B_03022075, E2B_02726169.

Organization: Health Canada

31 page(s)
August 2022

Req # A-2022-000295

Adverse Drug Reactions (ADRs) for Abilify. Report numbers: 000978703, 000980697, E2B_04984685, E2B_04986528, E2B_05006894, 000985149, 000985191. ADR for: Abilify maintena. Report numbers: E2B_05048808, E2B_05028169, 000982813.

Organization: Health Canada

118 page(s)
August 2022

Req # A-2022-000300

Adverse Drug Reactions (ADRs) for Celexa. Report numbers: 948953, E2B_03986567, E2B_03994182, E2B_01900496, E2B_04227929, E2B_03168677, 952226. ADRs for Trintellix. Report numbers: E2B_04003507, 950171, 949146.

Organization: Health Canada

364 page(s)
August 2022

Req # A-2022-000301

Adverse Drug Reactions (ADRs) for Ciraplex. Report numbers: E2B_04198941, E2B_04198882, E2B_04199428, E2B_04199003, E2B_04308961. ADRs for Celexa. Report numbers: 953509, E2B_04105198, 953821, 961553, 954509.

Organization: Health Canada

103 page(s)
August 2022

Req # A-2022-000307

Adverse Drug Reaction (ADR). Report number: E2B_05072677.

Organization: Health Canada

12 page(s)
August 2022

Req # A-2022-000311

Adverse Drug Reactions (ADRs). Report numbers: E2B_05276177, E2B_05217270, 000986745, E2B_05285073, E2B_05276203, E2B_05272499.

Organization: Health Canada

125 page(s)
August 2022

Req # A-2022-000313

Adverse Drug Reaction (ADR) for Chlorhexidine. Report number: 000982045.

Organization: Health Canada

4 page(s)
August 2022

Req # A-2022-000315

Adverse Drug Reactions (ADRs) for Chlorhexidine. Report numbers: E2B_03094730, E2B_02719108, 000733088, E2B_05078613.

Organization: Health Canada

27 page(s)
August 2022
Date modified: